Is the trade of cannabis cuttings legal in Germany?
Dr. Ferdinand Weis, a lawyer specialising in cannabis law and board member of the industry association Cannabiswirtschaft (BvCW), expresses the opinion that the trade in cannabis cuttings is legal. However, the debate on the legality of the cannabis cuttings trade in Germany is still ongoing.
The discourse surrounding the legality of the cannabis cuttings trade in Germany reflects both the complexity of the national legal framework and the growing pains of an emerging industry.
Dr. Ferdinand Weis, a lawyer specialising in cannabis law and board member of the industry association Cannabiswirtschaft (BvCW), expresses the opinion that the trade with cannabis cuttings is legal.
Dr. Ferdinand Weis
It began with a letter of advice from a consumer protection officer from the Federal Ministry of Food and Agriculture (BMEL), who rashly and without sound reasoning labelled the trade of cannabis cuttings as illegal. This position was quickly revised by higher-ups in the ministry and referred to a reassessment of existing policy and a move towards a more balanced approach that takes into account the nuances of the cannabis trade and attempts to find a satisfactory solution for all parties involved.
Dr. Weis, after a thorough review of the current legal framework, posits that trading cannabis cuttings can indeed comply with German law, provided specific conditions are met. One critical stipulation is that the cuttings must not be planted in soil but rather "embedded" in non-soil mediums like rockwool. This distinction is crucial as it pertains to the regulation of how cannabis plants are cultivated and sold.
Moreover, the debate is not only about the cuttings themselves, but also about the mother plants from which they are derived. Here, Dr. Weis continues to express reservations about their production, likely due to the possibility of these plants being used for the illicit propagation of cannabis, which poses legal and regulatory challenges.
Luisa Pfau
This nuanced interpretation by Dr. Weis points to a broader issue within the cannabis industry in Germany— the need for clearer regulations that reflect the complexities of cannabis cultivation and sales. The current state of affairs, where initial governmental responses can be hastily issued and then retracted, underscores a regulatory environment that is still in flux.
This instability can lead to confusion and hinder the development of a sector that many see as promising for economic growth and medical advancement. Stakeholders are calling for regulations that are not only clear and enforceable but also adaptable to the advancements in cannabis cultivation technology and market dynamics.
The goal remains to foster a regulated market that ensures safety and accessibility while promoting the agricultural and economic benefits of cannabis.
